1. Home
  2. OGN vs HASI Comparison

OGN vs HASI Comparison

Compare OGN & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • HASI
  • Stock Information
  • Founded
  • OGN 1923
  • HASI 1981
  • Country
  • OGN United States
  • HASI United States
  • Employees
  • OGN N/A
  • HASI N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • HASI Real Estate Investment Trusts
  • Sector
  • OGN Health Care
  • HASI Real Estate
  • Exchange
  • OGN Nasdaq
  • HASI Nasdaq
  • Market Cap
  • OGN 4.0B
  • HASI 3.3B
  • IPO Year
  • OGN N/A
  • HASI 2013
  • Fundamental
  • Price
  • OGN $15.48
  • HASI $28.02
  • Analyst Decision
  • OGN Hold
  • HASI Strong Buy
  • Analyst Count
  • OGN 5
  • HASI 13
  • Target Price
  • OGN $20.80
  • HASI $39.46
  • AVG Volume (30 Days)
  • OGN 2.9M
  • HASI 1.3M
  • Earning Date
  • OGN 02-13-2025
  • HASI 02-13-2025
  • Dividend Yield
  • OGN 7.23%
  • HASI 5.99%
  • EPS Growth
  • OGN N/A
  • HASI 14.02
  • EPS
  • OGN 3.33
  • HASI 1.62
  • Revenue
  • OGN $6,403,000,000.00
  • HASI $140,172,000.00
  • Revenue This Year
  • OGN $2.06
  • HASI N/A
  • Revenue Next Year
  • OGN $1.85
  • HASI $13.09
  • P/E Ratio
  • OGN $4.65
  • HASI $17.33
  • Revenue Growth
  • OGN 2.24
  • HASI 2.29
  • 52 Week Low
  • OGN $13.87
  • HASI $24.00
  • 52 Week High
  • OGN $23.10
  • HASI $36.56
  • Technical
  • Relative Strength Index (RSI)
  • OGN 50.46
  • HASI 48.86
  • Support Level
  • OGN $15.26
  • HASI $27.35
  • Resistance Level
  • OGN $15.90
  • HASI $30.90
  • Average True Range (ATR)
  • OGN 0.63
  • HASI 0.97
  • MACD
  • OGN 0.04
  • HASI 0.08
  • Stochastic Oscillator
  • OGN 35.19
  • HASI 26.90

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.

HA Sustainable Infrastructure Capital Inc is a climate investment firm that actively partners with clients to deploy real assets that facilitate the energy transition. It invests in behind-the-meter (BTM) building or facility-specific distributed energy projects which reduce energy usage or cost, Grid-connected (GC) renewable energy projects that deploy cleaner energy sources, such as solar, solar-plus-storage, and onshore wind, to generate power production and Fuels, Transport & Nature projects.

Share on Social Networks: